• Alfasigma acquires the European license for bentracimab from PhaseBio prnasia
    June 22, 2021
    Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc., for the commercialization of bentracimab in 49 countries across Europe and other key markets.
  • Alfasigma: It's Vein Week from 5th to 11th of April prnasia
    April 01, 2021
    Venous-lymphatic World International Network foundation (v-WIN), a no profit global organization dedicated to research and education in the venous & lymphatic field has developed a public and health professional awareness not-for-profit project called ...
PharmaSources Customer Service